Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
58,918,990
-
Share change
-
+801,520
-
Total reported value
-
$3,740,916,935
-
Put/Call ratio
-
78%
-
Price per share
-
$63.50
-
Number of holders
-
165
-
Value change
-
+$48,975,164
-
Number of buys
-
95
-
Number of sells
-
65
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2019
As of 30 Jun 2019 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 58,918,990 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Capital Research Global Investors, Capital International Investors, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, STATE STREET CORP, Capital World Investors, and FEDERATED INVESTORS INC /PA/.
This table shows 165 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.